Vaccine effectiveness against hospitalization ranged from 28% during the 2021-2022 flu season to 67% in the 2023-2024 season ...

Dr. Michael Calderwood, an epidemiologist at Dartmouth Hitchcock Medical Center in Lebanon, said this flu season has been ...

The U.S. Centers for Disease Control and Prevention is halting testing for over two dozen infectious diseases. On March 30, the CDC announced that a host of tests are “offline” for illnesses like ...

In Danish adults aged 40 years or older, laboratory-confirmed influenza was linked to a sharp short-term rise in first-time ...

Thirty-day COVID-19 mortality rates have declined since 2020 but remain comparable to or slightly higher than influenza A mortality rates in recent years.

This season’s influenza vaccine may have been less effective than last season’s, because it was not well matched against the flu strains in circulation, according to an analysis ...

April 6, 2026 / Moderna, Inc. (NASDAQ:MRNA) today announced that the Company will present late-breaking oral presentations on ...

Influenza vaccination could significantly reduce the risk of influenza-associated heart attack and stroke even among people ...

The global influenza vaccines market is projected to reach USD 13.46 billion by 2031, growing at a CAGR of 7.49%, led by North America, with Asia-Pacific emerging as a high-growth region driven by ...

Researchers from Leiden University, University of York, University of Barcelona/IQTCUB/ICREA and The Francis Crick Institute ...

Severe respiratory viral infection increases risk for lung cancer, according to study results.The findings — derived from work in murine models and retrospective analyses of data from humans — ...